Elder Financial Abuse is on the Rise
Do you suspect, or know, that somebody has been stealing from you? Maybe it’s items from your home? Or maybe it’s your money? Or perhaps you’re being pressured by someone to keep giving them cash. If so, you are not alone. It’s called elder abuse.
Publishing Tycoon’s Estate Planning Surprise
When the Scholastic Publishing Tycoon died suddenly his family was shocked they would not inherit his $1.2 billion company.
Lessons from Country Star Charley Pride’s Disputed Will
There’s a battle brewing over the estate of Grammy-winning country star Charley Pride, fueled by a son few knew existed.
Is Medicaid the Answer to Rising Costs?
Planning for long-term care can be an intimidating process, especially when it comes to decoding the specifics of resources, like Medicaid and Veterans Pensions. Working with the help of an experienced elder law planning attorney allows people to prepare for the future and save time, money and stress.
How to Prepare for Higher Taxes
President Biden’s proposal to eliminate the step-up for calculating inheritance taxes targets a tactic that has long been a wealth-preservation tool. What are some of the ramifications of the proposal and what, after political wrangling, could be the tax implications for large inherited assets?
Power of Attorney Dos and Don’ts
We see recurring confusion about what it means to be appointed with authority over money in a Durable Power of Attorney (DPOA) for aging parents.
What Should Be Included in Your Estate Plan?
The best time to do estate planning is ten years ago, but the second-best time to do so is now.
Should You Claim Social Security Early?
Experts often recommend postponing claiming Social Security. However, there are situations in which you should claim sooner.
How Do You Divide Inheritance among Children?
First, before making a gift or bequest outright to your youngest son, consider whether now or in the future he will possibly be eligible for governmental assistance based on his disability and his own assets.
What’s the Criticism of the New Alzheimer’s Drug?
The controversy surrounding the Biogen drug, including its potential cost, comes against a landscape of massive, unmet need for dementia treatment and a disease that costs the U.S. as much as $259 billion annually. More than six million Americans have Alzheimer’s or another form of dementia, according to estimates from the Alzheimer’s Association, and by 2050 that number could reach over 12 million people at a cost of $1 trillion annually.
